Delivery Order SPE2DB24D3014-SPE2DB25FKRYZ
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,108,607 units of the biologic medication Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits, with a ceiling value of $25,267.75. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. AmerisourceBergen holds a $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,952,657 units of the biologic medication CIMZIA (certolizumab pegol) 2x200 mg/mL syringe kits. The contract has a ceiling value of $30,261.29 and an ultimate completion date of September 27, 2024. This order is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,269,570 units of the pharmaceutical product Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits. The $46,505.06 firm-fixed-price contract has a completion date of February 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,984,016 units of the medication Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits. The contract is a firm fixed-price delivery order with a ceiling value of $15,124.90 and a period of performance through April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,308,593 units of Cimzia 2x200 mg/mL syringe kits, a specialty pharmaceutical product. The contract has a firm fixed price of $37,453.55 and a completion date of August 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,420.47 firm-fixed-price contract is for the supply of 4,567,997,862 units of the biologic medication Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits. This order is not set-aside and represents open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,076,721 units of the biologic medication CIMZIA (certolizumab pegol) 2x200 mg/mL syringe kits, with a ceiling value of $6,892.75 and a period of performance through April 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,530.53, is for the delivery of 4,568,011,682 units of the biologic medication Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits. The contract has a firm fixed price pricing type and an ultimate completion date of April 24, 2025. This delivery order is part of a larger...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,980.48, is for the supply of 4,567,967,953 units of the biologic medication CIMZIA (certolizumab pegol) 2x200 mg/mL syringe kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,451,455 units of CIMZIA 2X200 MG/ML syringe kits, with a firm fixed price of $15,078.48 and a completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...